Pancreatic Cancer Research

ResearcherDokuz Eylül UniversityNo recent work listed

Mustafa Oktay Tarhan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8502-4348; OpenAlex author ID A5108259282. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers

Papers 3

  1. An analysis of adjuvant treatment strategies in operated pancreatic cancer patients: An Izmir oncology group study. Last author DOI 10.4103/ijc.ijc_318_18↗
  2. Prognostic role of De Ritis and basal neutrophil to lymphocyte ratio in patients with advanced stage pancreatic cancer [Izmir Oncology Group (IZOG) Study]. Last author PMID 32521907↗
  3. Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer. Last author DOI 10.7314/apjcp.2014.15.17.7119↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Umut Varol · 3 shared papers, 2014–2020 · strength 0.24
  2. Ahmet Alacacıoğlu · 3 shared papers, 2014–2020 · strength 0.24
  3. İbrahim Yıldız · 1 shared paper, 2014 · strength 0.04
  4. İbrahim Vedat Bayoğlu · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.